Yanmeng Wang

997 total citations
28 papers, 715 citations indexed

About

Yanmeng Wang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanmeng Wang has authored 28 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanmeng Wang's work include Tissue Engineering and Regenerative Medicine (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Pluripotent Stem Cells Research (4 papers). Yanmeng Wang is often cited by papers focused on Tissue Engineering and Regenerative Medicine (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Pluripotent Stem Cells Research (4 papers). Yanmeng Wang collaborates with scholars based in China, Belgium and Ireland. Yanmeng Wang's co-authors include Haibin Wang, Qiuxia Lin, Jin Zhou, Cuimi Duan, Zhiqiang Liu, Changyong Wang, Dexue Li, Feng Cao, Yan Wang and Zhiyan Du and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.

In The Last Decade

Yanmeng Wang

26 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanmeng Wang China 14 321 283 242 154 89 28 715
Chunying Shi China 19 312 1.0× 259 0.9× 292 1.2× 174 1.1× 57 0.6× 47 878
David R. Maestas United States 11 306 1.0× 214 0.8× 244 1.0× 268 1.7× 87 1.0× 17 924
Yuelong Cao China 12 390 1.2× 206 0.7× 226 0.9× 214 1.4× 65 0.7× 39 941
Wan Xing Hong United States 13 201 0.6× 226 0.8× 395 1.6× 186 1.2× 187 2.1× 25 1.2k
Han Na Yang South Korea 19 150 0.5× 265 0.9× 321 1.3× 196 1.3× 190 2.1× 24 892
Junji Komori Japan 13 587 1.8× 246 0.9× 213 0.9× 153 1.0× 41 0.5× 26 835
Longmei Zhao China 19 222 0.7× 144 0.5× 251 1.0× 108 0.7× 147 1.7× 38 842
Hannah A. Strobel United States 16 205 0.6× 188 0.7× 268 1.1× 297 1.9× 173 1.9× 36 790
Christopher Tsao United States 7 175 0.5× 163 0.6× 266 1.1× 180 1.2× 44 0.5× 13 644
Maximilian G. Burger Switzerland 9 193 0.6× 193 0.7× 297 1.2× 320 2.1× 141 1.6× 12 827

Countries citing papers authored by Yanmeng Wang

Since Specialization
Citations

This map shows the geographic impact of Yanmeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanmeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanmeng Wang more than expected).

Fields of papers citing papers by Yanmeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanmeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanmeng Wang. The network helps show where Yanmeng Wang may publish in the future.

Co-authorship network of co-authors of Yanmeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanmeng Wang. A scholar is included among the top collaborators of Yanmeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanmeng Wang. Yanmeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Rong, Yanmeng Wang, Timo W.M. De Groof, et al.. (2024). AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia. Theranostics. 14(7). 2656–2674. 6 indexed citations
2.
Wang, Yanmeng, et al.. (2024). Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy. Cell Communication and Signaling. 22(1). 320–320. 10 indexed citations
3.
Zhang, Xinhe, Ningning Wang, Bing Chang, et al.. (2023). Clinical features and relapse risks factors of IgG4 related disease: a single-center retrospective study. Clinical and Experimental Medicine. 23(7). 3527–3538. 3 indexed citations
4.
Wang, Yanmeng, Philip Vlummens, Kim De Veirman, et al.. (2023). S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma. Haematologica. 109(1). 256–271. 8 indexed citations
6.
Zhang, Xinhe, Xinping Zhong, Xuyong Lin, et al.. (2022). Tuberous Sclerosis Complex With Multiple Organ Tumors: Case Report and Literature Review. Frontiers in Oncology. 12. 916016–916016. 2 indexed citations
7.
Maes, Anke, Philip Vlummens, Elke De Bruyne, et al.. (2022). System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. Cancer Letters. 535. 215649–215649. 22 indexed citations
8.
Wang, Yanmeng, Nan Lv, Dan Zhang, et al.. (2020). Hypoxia Impairs NK Cell Cytotoxicity through SHP‐1‐Mediated Attenuation of STAT3 and ERK Signaling Pathways. Journal of Immunology Research. 2020(1). 4598476–4598476. 58 indexed citations
9.
Zhang, Dan, Kim De Veirman, Rong Fan, et al.. (2020). ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation. Stem Cell Research & Therapy. 11(1). 516–516. 33 indexed citations
10.
Huang, Lingjuan, Yanmeng Wang, Ju Bai, et al.. (2020). Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma. Cell Stress and Chaperones. 25(2). 357–367. 23 indexed citations
11.
Zhang, Dan, Gang Cui, Lei Li, et al.. (2019). Hypoxia promotes osteosarcoma cell proliferation and migration through enhancing platelet-derived growth factor-BB/platelet-derived growth factor receptor-β axis. Biochemical and Biophysical Research Communications. 512(2). 360–366. 34 indexed citations
12.
Liu, Zhiqiang, Haibin Wang, Yan Wang, et al.. (2012). The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 33(11). 3093–3106. 214 indexed citations
13.
Lin, Qiuxia, Qiang Fu, Ye Zhang, et al.. (2010). Tumourigenesis in the Infarcted Rat Heart is Eliminated Through Differentiation and Enrichment of the Transplanted Embryonic Stem Cells. European Journal of Heart Failure. 12(11). 1179–1185. 17 indexed citations
14.
Wang, Haibin, Xuelian Zhang, Yanmin Li, et al.. (2010). Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive Chitosan hydrogel. The Journal of Heart and Lung Transplantation. 29(8). 881–887. 87 indexed citations
15.
Zhou, Jin, Ye Zhang, Qiuxia Lin, et al.. (2010). Embryoid bodies formation and differentiation from mouse embryonic stem cells in collagen/Matrigel scaffolds. Journal of genetics and genomics. 37(7). 451–460. 28 indexed citations
17.
Lü, Shuanghong, Sheng Liu, Wenjun He, et al.. (2008). Bioreactor Cultivation Enhances NTEB Formation and Differentiation of NTES Cells into Cardiomyocytes. Cloning and Stem Cells. 10(3). 363–370. 21 indexed citations
18.
Zhang, Jichang, Lijian Zhang, Yanmeng Wang, & Wei Li. (1998). A study of endoscopic treatment of advanced esophageal and gastric carcinoma. Chinese Journal of Cancer Research. 10(3). 233–234.
19.
Jin, Maolin, et al.. (1994). Photodynamic therapy for upper gastrointestinal tumours over the past 10 years. Seminars in Surgical Oncology. 10(2). 111–113. 24 indexed citations
20.
Jin, Maolin, et al.. (1994). High‐dose mitomycin C‐containing regimens in the treatment of advanced gastric cancer. Seminars in Surgical Oncology. 10(2). 114–116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026